15 results
424B5
LIXT
Lixte Biotechnology Holdings Inc
14 Apr 22
Prospectus supplement for primary offering
6:15am
in foreign countries; more stringent privacy requirements for data to be supplied to our operations in the U.S., e.g., General Data Protection Regulation
424B5
LIXT
Lixte Biotechnology Holdings Inc
1 Mar 21
Prospectus supplement for primary offering
4:21pm
to be supplied to our operations in the U.S., e.g., General Data Protection Regulation in the European Union;
unexpected changes in tariffs, trade
8-K
EX-10.1
026bajnh9 tiofw
22 Jan 21
Entry into a Material Definitive Agreement
2:00pm
424B4
f1gp2
27 Nov 20
Prospectus supplement with pricing info
5:25pm
8-K
EX-1.1
8joy7l7 hn10
27 Nov 20
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
4:43pm
S-1/A
ci2bpp5 cben
13 Oct 20
IPO registration (amended)
10:00am
S-1/A
EX-1.1
psixirgs j4kud5u
13 Oct 20
IPO registration (amended)
10:00am
S-1
ngftgsg yl
3 Sep 20
IPO registration
5:05pm
8-K
EX-10.1
12f34tfr1 akl7mrjbve
6 Aug 19
Entry into a Material Definitive Agreement
3:29pm
- Prev
- 1
- Next